CHIMERA INVESTMENT CORP (CIM) Stock Analyst Ratings
NYSE:CIM - New York Stock Exchange, Inc. - US16934Q8024 - REIT - Currency: USD
ChartMill assigns a Buy % Consensus number of 73% to CIM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.07. This target is 15.49% above the current price.
CIM was analyzed by 8 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about CIM.
In the last month the buy percentage rose by 24 points. So the trust of analysts is improving.
CIM was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-14 | UBS | Upgrade | Neutral -> Buy |
| 2025-01-23 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-08-08 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2024-07-10 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2023-12-06 | UBS | Initiate | Neutral |
| 2023-05-19 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-05-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-05-09 | Keefe, Bruyette & Woods | Maintains | Market Perform |
| 2023-04-24 | Keefe, Bruyette & Woods | Maintains | Market Perform |
| 2023-03-09 | Credit Suisse | Reiterate | Neutral |
| 2023-03-07 | RBC Capital | Reiterate | Outperform |
| 2022-10-05 | RBC Capital | Maintains | Outperform |
| 2022-07-18 | Barclays | Maintains | Underweight |
| 2022-05-23 | RBC Capital | Maintains | Outperform |
| 2022-04-27 | Barclays | Maintains | Underweight |
| 2022-01-10 | Barclays | Maintains | Underweight |